Patient and Physician Preferences for Acute Myeloid Leukemia Maintenance Treatments Following Hematopoietic Stem Cell Transplantation
Lalit Saini,1 James D Griffin,2 Bhavik J Pandya,3 Manasee V Shah,3 Mo Zhou,4 Hongbo Yang,4 Yan Song,4 Deborah A Marshall5 1London Health Sciences Centre, London, Ontario, Canada; 2Dana-Farber Cancer Institute, Boston, MA, USA; 3Astellas Pharma, Inc, Northbrook, IL, USA; 4Analysis Group, Boston, MA,...
Main Authors: | Saini L, Griffin JD, Pandya BJ, Shah MV, Zhou M, Yang H, Song Y, Marshall DA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-11-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/patient-and-physician-preferences-for-acute-myeloid-leukemia-maintenan-peer-reviewed-fulltext-article-PPA |
Similar Items
-
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
by: Li Xuan, et al.
Published: (2021-01-01) -
Patient and physician preferences for atopic dermatitis injection treatments in Japan
by: Yukari Okubo, et al.
Published: (2020-11-01) -
Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia
by: Audrey Delmas, et al.
Published: (2023-05-01) -
Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States
by: Eytan M. Stein, et al.
Published: (2018-09-01) -
Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo-therapy
by: Thomas Büchner, et al.
Published: (2004-03-01)